"Assessment of AMBRTM as a model for high-throughput cell culture process development strategy"
written by Sarath Moses, Matthew Manahan, Alexandre Ambrogelly, Wai Lam W. Ling,
published by Advances in Bioscience and Biotechnology, Vol.3 No.7, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Enhancing the functionality of a microscale bioreactor system as an industrial process development tool for mammalian perfusion culture
2019
[2] Scale‐Down Model Qualification of ambr® 250 High‐Throughput Mini‐Bioreactor System for 2 Commercial‐Scale mAb Processes
2019
[3] A novel scale‐down mimic of perfusion cell culture using sedimentation in an automated microbioreactor (SAM)
2019
[4] Highly parallel microbioreactors for cell line development based on well plates with functional lids
2018
[5] Transcriptome analysis for the scale-down of a CHO cell fed-batch process
Journal of Biotechnology, 2018
[6] Development and application of a milliliter-scale bioreactor for continuous microbial cultivations
Thesis, 2018
[7] High throughput automated microbial bioreactor system used for clone selection and rapid scale‐down process optimization
Biotechnology progress, 2018
[8] Scale‐Down Model Development in ambr™ systems: An Industrial Perspective
Biotechnology journal, 2018
[9] The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing
Trends in Biotechnology, 2018
[10] At‐line raman spectroscopy and design of experiments for robust monitoring and control of miniature bioreactor cultures
2018
[11] Platform technologies for automated bioprocess development
2018
[12] High-Throughput Process Development for Biopharmaceuticals
Advances in Biochemical Engineering/Biotechnology book series, 2017
[13] Microbioreactor systems for accelerated bioprocess development
Biotechnology journal, 2017
[14] Comparison of Spectroscopy Technologies for Improved Monitoring of Cell Culture Processes in Miniature Bioreactors
Biotechnology progress, 2017
[15] Cell Line Development for Biomanufacturing Processes
2017
[16] High throughput automated microbial bioreactor system used for clone selection and rapid scale‐down process optimisation
Biotechnology progress, 2017
[17] Optimizing performance of semi‐continuous cell culture in an ambr15™ microbioreactor using dynamic flux balance modeling
Biotechnology progress, 2017
[18] Disposable Bioreactors
Current Developments in Biotechnology and Bioengineering, 2017
[19] Controlling the time evolution of mAb N‐linked glycosylation, Part I: Microbioreactor experiments
Biotechnology progress, 2016
[20] Lessons learned in building high throughput process development capabilities
Engineering in Life Sciences, 2016
[21] Scalable Manufacture for Cell Therapy Needs
Bioreactor Design: Design, Operation and Novel Applications, 2016
[22] Controlling the time evolution of mAb N‐linked glycosylation‐Part I: Micro‐bioreactor experiments
Biotechnology progress, 2016
[23] High‐throughput screening and selection of mammalian cells for enhanced protein production
Biotechnology journal, 2016
[24] High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylation
Journal of Biotechnology, 2016
[25] Controlling the time evolution of mAb N‐linked glycosylation‐Part II: Model‐based predictions
Biotechnology progress, 2016
[26] Lessons learned in building high‐throughput process development capabilities
Engineering in Life Sciences, 2016
[27] Mass Transfer and Mixing Across the Scales in Animal Cell Culture
Animal Cell Culture, 2015
[28] Development of a mathematical model for animal cell culture without pH control and its application for evaluation of clone screening outcomes in shake flask culture
Journal of Chemical Technology and Biotechnology, 2015
[29] Pushing the limits of high-throughput chromatography process development: current state and future directions
Pharmaceutical Bioprocessing, 2015
[30] Cell therapies: why scale matters
Pharmaceutical Bioprocessing, 2015
[31] Integration of cell line and process development to overcome the challenge of a difficult to express protein
Biotechnology progress, 2015
[32] High‐throughput purification tools for rapid upstream process development are interchangeable for biologics
Engineering in Life Sciences, 2015
[33] Cell line development for biomanufacturing processes: recent advances and an outlook
Biotechnology letters, 2015
[34] Leveraging high‐throughput technology to accelerate the time to clinic: A case study of a mAb
Engineering in Life Sciences, 2015
[35] Application of high‐throughput mini‐bioreactor system for systematic scale‐down modeling, process characterization, and control strategy development
Biotechnology progress, 2015
[36] High-throughput screening and automation approaches for the development of recombinant therapeutic proteins
Pharmaceutical Bioprocessing, 2015
[37] The role of high-throughput mini-bioreactors in process development and process optimization for mammalian cell culture
Pharmaceutical Bioprocessing, 2015
[38] Screening and assessment of performance and molecule quality attributes of industrial cell lines across different fed‐batch systems
Biotechnology progress, 2015
[39] Bioprocess Engineering Framework to Control Protein N-linked Glycosylation
2015
[40] Mikrodosiertechnik und Mikrosensoren zur pH?Kontrolle in Parallelbioreaktoren
2014
[41] Are automated disposable small-scale reactors set to dominate the future of pharmaceutical bioprocess development?
Pharmaceutical Bioprocessing, 2014
[42] Modulation of mAb quality attributes using microliter scale fed‐batch cultures
Biotechnology progress, 2014
[43] Mikrodosiertechnik und Mikrosensoren zur pH-Kontrolle in Parallelbioreaktoren
2014
[44] High‐throughput miniaturized bioreactors for cell culture process development: Reproducibility, scalability, and control
Biotechnology progress, 2014
[45] Challenges in industrial fermentation technology research
Biotechnology journal, 2014
[46] Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study
Biotechnology and bioengineering, 2013
[47] Novel Platform Technology for Scale Down and Process Optimization for Regenerative Medicine
2013
[48] Experimental and Mathematical Framework to Control N-Linked Glycosylation
Project view, 2011